Gastrointestinal tolerance of allulose in Korean adults

Gastrointestinal tolerance of allulose

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002216

Enrollment

Registered

2017-02-08

Start date

2016-09-22

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Occasional ingestion: The starting dose was 0.1g/ kgBW per day Sucrose. After wash-out period of 1 weeks, dose increased by 0.1g/ kgBW per day until 1.0/ kg BW per day. (10 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male and female volunteers aged 20-40 years without serious disease

Exclusion criteria

Exclusion criteria: Hypertensive taking diuretic Patient taking oral hypoglycemic agent or insulin injection Serious cardiac, renal, hepatic, thyroid or cerebrovascular disease Serious cystic or gastrointestinal disease, gout or porphyria Psychiatric problems such as depressive disorder, schizophrenia , alchol-holic, drug intoxication. Using functional food products that may affect the results of this study A history of surgery within 6 months Cancer diagnosis and treatment Asthma or other allergy A history of surgery within 6 months Drinking frequently Hard to follow the taking experimental material schedule Pregnant or lactancy period

Design outcomes

Primary

Measure	Time frame
Gastrointestinal symptom ( Nausea, Bloating, Borborygmi, Colic, Flatulence , Headache, Appetite diminution, Diarrhea)	—

Secondary

Measure	Time frame
Frequncy of bowel movents and type	—

Countries

Korea, Republic of

Contacts

Public ContactYoungji Han

Kyungpook National University

dynamic03@hanmail.net+82-53-950-7937

Outcome results